Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Semin Oncol. 2011 Oct;38(5):682–692. doi: 10.1053/j.seminoncol.2011.04.011

Figure 3.

Figure 3

Outcome after failure of hypomethylating agent + valproic acid-based combination therapy. AML, acute myeloid leukemia. CR, complete remission. (Adapted with permission from Kadia, et. al.17)